安根在印度海得拉巴开设了一个200M美元的技术中心,以促进药物开发方面的AI和数据科学。 Amgen opens a $200M tech center in Hyderabad, India, to boost AI and data science in drug development.

美国生物技术公司Amgen在印度海得拉巴开设了一个新的价值2亿美元的技术和创新中心,目的是通过AI和数据科学加强数字能力和支持药物发展。 Amgen, a US biotech company, has opened a new $200 million technology and innovation center in Hyderabad, India, aiming to enhance digital capabilities and support drug development through AI and data science. 该设施已经雇用了300名雇员,计划到年底使总数达到2 000名雇员。 The facility, which has already hired 300 employees, plans to reach a total of 2,000 employees by the end of the year. 中心是安根在印度扩张的一部分, 这是全球技术中心日益增长的枢纽。 The center is part of Amgen's expansion in India, a growing hub for global technology centers.